News in the Life Sciences Industry

STOCKHOLM, Oct. 23, 2018 /PRNewswire/ -- Margareta Lehmann, President of Health and Medical Solutions and a member of Essity's Executive Management Team, is stepping down from her position due to retirement.

STOCKHOLM, Oct. 23, 2018 /PRNewswire/ -- Cyxone AB (publ) announced today that the company has selected the clinical site that will carry out the drug candidate T20K's first in man study. The clinical site located in Western Europe has been carefully evaluated based on a... Read more ››

STOCKHOLM, Oct. 23, 2018 /PRNewswire/ -- New results of intralymphatic treatment with the diabetes vaccine Diamyd® indicate the induction of a long-term immune response that supports the positive clinical results shown in the DIAGNODE-1 trial. The results are presented this week at the international... Read more ››

STOCKHOLM, Oct. 23, 2018 /PRNewswire/ -- On 31 October, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) will publish its report for the third quarter 2018.

UPPSALA, Sweden, Oct. 22, 2018 /PRNewswire/ -- OssDsign AB, the Swedish designer, manufacturer and distributor of regenerative implants for cranial and facial reconstruction, today announced that it has received 510(k) clearance by the US FDA for marketing and sale of its latest product,... Read more ››

STOCKHOLM, Oct. 21, 2018 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA-B) announced today that the European Patent Office (EPO) has issued a decision to grant the company's patent application in Europe, EP09738534.8, for its Parkinson's disease concept patent. The decision states... Read more ››

STOCKHOLM, October 19, 2018 /PRNewswire/ --

GOTHENBURG, Sweden, Oct. 18, 2018 /PRNewswire/ -- "We continue to show strong sales growth, but mix effects have a negative effect on our gross margin", says Mattias Perjos, President & CEO at Getinge. "I am not satisfied that despite higher volumes we have only limited productivity effects... Read more ››

GOTHENBURG, Sweden, Oct. 18, 2018 /PRNewswire/ -- Atrium Medical Corporation, a subsidiary of Getinge, has signed an agreement to divest its biosurgery business to HJ Capital 1, the parent company of SeCQure Surgical Corporation, a global medical device company. The deal is expected to close... Read more ››

STOCKHOLM, Oct. 17, 2018 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announced today plans to reduce activities not critical to its development pipeline of drug candidates as part of its enhanced focus on clinical stage projects.